Profile picture of: Sabrina Wurzba
 

Institution

Faculty of Medicine – McGill Univeristy


Department of Otolaryngology – Head and Neck Surgery

Research Interests

N/A

 

Topics to speak on:

head and neck cancer, risk factors, molecular biology, tumor progression, metastasis, tumor environment

Biography

Dr Wurzba DDS, MSc, PhD is assistant professor at the Department of Otolaryngology – Head and Neck Surgery at McGill University and project director at the Lady Davis Institute for Medical Research – Segal Cancer Center.  She obtained her DDS degree from University of Sao Paulo State, Brazil and her MSc and PhD in Pathology and Molecular Biology at University of Campinas (UNICAMP, Brazil). She did a postdoctoral training in Genetic/Genomics in Oncology under supervision of Dr Luiz Paulo Kowalski, a renowned expert at AC Camargo Cancer Center, gaining a vast experience in the field. In 2010, she joined the ENT Department at the Jewish General Hospital where she continued her research focus on improving outcomes for patients with head and neck cancer through optimized detection and use of personalized targeted therapeutics. She pursued a complementary training in Experimental Medicine. In collaboration with Dr Moulay Alaoui-Jamali, a professor and scientist from the Segal Cancer Center and Lady Davis Institute for Medical Research, she carried out fundamental research to understand the mechanism of tumor progression including the establishment of orthotopic metastatic models using tissues samples from patients with head and neck cancer. In 2014, Dr. Wurzba became assistant professor and researcher in the Department of Head and Neck, where she is now leading basic and translational research with a primary goal to improve prevention, early tumor detection, and discover alternative therapeutic approaches for patients with advanced disease.

Dr Wurzba’s research has been published in several peer-reviewed biomedical and medical international journals and she has contributed to book chapters related to the field of oncology science. She has been presented at national and international conferences, including the American Association Head and Neck Society, the Canadian Society of Otolaryngology, and the International Academy of Oral Oncology. She also has been serving on several national and international grant panels, editorial boards of biomedical/medical journals.

Activities